About Resistell
Resistell is a company based in Basel (Switzerland) founded in 2017.. Resistell has raised $13.44 million across 6 funding rounds from investors including TRUMPF, Pfizer and Zurcher Kantonalbank. Resistell operates in a competitive market with competitors including OpGen, NOWDiagnostics, Avails Medical, HandyLab and DNA Electronics, among others.
- Headquarter Basel, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Resistell Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.44 M (USD)
in 6 rounds
-
Latest Funding Round
$9.13 M (USD), Series B
Dec 19, 2022
-
Investors
TRUMPF
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Resistell
Resistell has successfully raised a total of $13.44M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $9.13 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $9.1M
-
First Round
First Round
(07 Dec 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series B - Resistell | Valuation | bp Launchpad | |
| Apr, 2022 | Amount | Grant - Resistell | Valuation |
investors |
|
| Aug, 2020 | Amount | Grant - Resistell | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Resistell
Resistell has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include TRUMPF, Pfizer and Zurcher Kantonalbank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided to deep-tech startups.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Resistell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Resistell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Resistell Comparisons
Competitors of Resistell
Resistell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, NOWDiagnostics, Avails Medical, HandyLab and DNA Electronics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
|
| domain | founded_year | HQ Location |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays and automation platforms are developed.
|
|
| domain | founded_year | HQ Location |
Semi-conductor-based NGS diagnostics for infectious diseases are offered.
|
|
| domain | founded_year | HQ Location |
Instruments and assays for molecular pathogen detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Resistell
Frequently Asked Questions about Resistell
When was Resistell founded?
Resistell was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Resistell located?
Resistell is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Is Resistell a funded company?
Resistell is a funded company, having raised a total of $13.44M across 6 funding rounds to date. The company's 1st funding round was a Grant of $2.94M, raised on Dec 07, 2018.
What does Resistell do?
Resistell was founded in 2017 in Basel, Switzerland, and operates within the diagnostics sector of healthcare. Antibiotic susceptibility testing is offered through a culture-based antibiogram, with diagnosis enabled by the detection of movement from living bacterial cells. This approach supports the identification of suitable antibiotics and required concentrations for patient treatment, facilitating informed clinical decisions in infectious disease management.
Who are the top competitors of Resistell?
Resistell's top competitors include Avails Medical, OpGen and Verax Biomedical.
Who are Resistell's investors?
Resistell has 10 investors. Key investors include TRUMPF, Pfizer, Zurcher Kantonalbank, European Union, and HEMEX.